Position in SUPN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$44,271,812
+$11,454,406 QoQ
Shares Held
856,487
+29.7% QoQ
Ownership
1.48%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 97.85659326995038.ToString("F0")%
Shared 0.ToString("F0")%
None 2.14340673004961.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Derivatives in SUPN
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$1,913,450
PutShares
38,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $1,741,757,397 across 53 Drug Manufacturers - Specialty & Generic names. SUPN ranks #11 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,730,785 | $441,016,092 | |
| 2 | VTRS |
Viatris Inc
|
13,717,622 | $185,325,071 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,826,245 | $145,366,498 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
5,618,728 | $104,058,841 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,409,165 | $73,431,349 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
114,419 | $67,848,177 | |
| 7 | ALKS |
Alkermes plc.
|
1,882,178 | $66,553,812 | |
| 8 | HLN |
Haleon plc
|
6,127,452 | $61,335,793 |
All Filings in SUPN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $44,271,812 | 856,487 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,913,450 | 38,500 | Put | Defined | 2026-03-25 | |
| 2025-12-31 | $32,817,406 | 660,310 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $55,582,539 | 1,163,058 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $28,254,116 | 896,387 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $26,991,075 | 824,155 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $33,771,702 | 933,952 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $28,050,680 | 899,637 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $15,791,407 | 590,333 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $10,741,033 | 314,894 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,920,450 | 239,131 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $4,337,035 | 157,310 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $5,746,659 | 191,173 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $10,281,385 | 283,781 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $11,373,699 | 318,859 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $7,505,626 | 221,732 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $8,892,407 | 307,483 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $17,778,617 | 550,081 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,708,270 | 264,344 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $6,977,137 | 261,610 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $7,739,250 | 251,356 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,055,696 | 193,113 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $8,711,397 | 346,240 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,151,543 | 247,195 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,675,418 | 238,965 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $9,262,150 | 514,850 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||